Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
277 EUR | -0.02% |
|
+3.09% | -2.15% |
12/06 | BMO Capital Adjusts Price Target on Sherwin-Williams to $360 From $377, Maintains Outperform Rating | MT |
12/06 | BMO Capital Adjusts Price Target on Sherwin-Williams to $360 From $377 | MT |
Strengths
- Analyst opinion has improved significantly over the past four months.
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
Weaknesses
- With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
- The company benefits from high valuations in earnings multiples.
- With an enterprise value anticipated at 3.6 times the sales for the current fiscal year, the company turns out to be overvalued.
- The company appears highly valued given the size of its balance sheet.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Sector: Commodity Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-2.15% | 75.33B | - | ||
-14.13% | 33.55B | B- | ||
-14.86% | 29.97B | A- | ||
-8.51% | 15.74B | B | ||
-0.30% | 14.33B | B+ | ||
+1.59% | 7.61B | B- | ||
-16.87% | 7.01B | B | ||
+6.39% | 3.51B | B- | ||
-10.04% | 3.11B | B+ | ||
-14.99% | 2.74B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- SHW Stock
- 4SHW Stock
- Ratings The Sherwin-Williams Company